To the best of our knowledge, IP-10 was tested in comparison to other autoimmune diseases in a few studies [3], galectin-9 was only compared to patients with primary APS [5], and soluble SIGLEC-1 was evaluated against systemic sclerosis [13]. Here, LGALS9 is linked to autoimmune polyendocrinopathy.